#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital hypotransferrinaemia Herpes simplex Non-Hodgkin's lymphoma refractory Deafness neurosensory Immune-mediated myositis Myelofibrosis Oesophageal carcinoma Central nervous system neoplasm Retinal artery occlusion Immune-mediated enterocolitis Optic glioma Splenic marginal zone lymphoma Liver abscess Dementia Piriformis syndrome More trials…

    Learn about Rare Diseases

    Pemphigoid Angiosarcoma non-metastatic – Basic Information Uterine leiomyosarcoma – Basic Information Alport’s syndrome – Basic Information Nephrotic syndrome – Diagnostics Thrombotic thrombocytopenic purpura – Basic Information Lymphatic malformation – Trials in Disease Bronchopulmonary dysplasia – Trials in Disease Ewing’s sarcoma recurrent Erdheim-Chester disease – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amiloride Hydrochloride Lumateperone Disodium Folinate Ag13909 Rezpegaldesleukin Thiamazole 6QC-ICG Bepirovirsen Vorinostat Phenazone Etripamil Anastrozole Letermovir Eptacog Alfa (Activated) Anhydrous Cyclophosphamide Methotrexate Disodium Mk-0482 Adrc Anhydrous Glucose Bp Emrusolmin More therapies…

    Learn about Your Condition

    Metachromatic leukodystrophy Oral lichen planus Hodgkin's disease recurrent Mixed dementia Alveolar proteinosis Candida infection Prolymphocytic leukaemia Hypersensitivity Hypotension Hepatobiliary cancer Nocturia Skin disorder Carotid artery occlusion Amnestic disorder Ataxia telangiectasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre hospitalier Emile Roux

Centre hospitalier Emile Roux

12 Boulevard Dr André Chantemesse, Le Puy-En-Velay, 43000, France

Want to learn more about this study or check if you can participate? Contact us.

  • A study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastrooesophageal cancer
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • FRUQUINTINIB
    • Tipiracil Hydrochloride
    • Trifluridine
    France Germany Spain

  • Study on Adjusting Adalimumab Treatment for Patients with Chronic Non-Infectious Uveitis

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Adalimumab
    France

  • Study on Continuing or Stopping Immunosuppressive Therapy with Rituximab in Patients with ANCA Vasculitis and End-stage Kidney Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    • End stage renal disease
    Investigated Drugs:
    • Azathioprine
    • Mycophenolate Mofetil
    • Prednisolone
    France

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!